Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.

导出 OA

翻译打印收藏纠错

作者： Vivek P,Chavda ^[1] ; Rajashri,Bezbaruah ^[2] ; Mansi,Athalye ^[3] ; Palak K,Parikh ^[4] ; Abu Sufiyan,Chhipa ^[5] ; Snehal,Patel ^[5] ; Vasso,Apostolopoulos ^[6]

作者单位： Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.;Department of Pharmaceutics, K B Institute of Pharmaceutical Education and Research, Kadi Sarva Vishwavidhyalaya, Gandhinagar 382023, Gujarat, India. ^[1] Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh 786004, Assam, India. ^[2] Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India. ^[3] Department of Pharmaceutical Chemistry and Quality Assurance, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India. ^[4] Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India. ^[5] Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia. ^[6]

关键词 COVID-19 SARS-CoV-2 replicating viral vector vaccine vaccine efficacy viral vector-based vaccine

主题词人类(Humans);接种(Vaccination);病毒疫苗(Viral Vaccines)

DOI 10.3390/v14040759

PMID 35458489

发布时间 2024-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交